According to the National Security Commission on Artificial Intelligence, more than 200 drugs are currently in short supply in the US, affecting critical care medications. The report highlights the importance of increasing transparency, promoting domestic manufacturing, and stockpiling critical medicines to prepare for crises. The pharmaceutical industry's globalization and consolidation have contributed to this problem, impacting patient care, the economy, and national security.
This whitepaper examines why consolidation in the pharmaceutical industry and a lack of supply chain visibility are primary causes, and how leveraging data from major vendors and wholesalers provides pharmacies valuable insights to optimize inventory management and automate orders — saving money while protecting patients.
Sponsored By: